This paper reports on reduced graphene oxide (rGO), tin oxide (SnO 2 ) and polyvinylidene fluoride (PVDF) tertiary nanocomposite thick film based flexible gas sensor. The nanocomposite of 0.90(PVDF) − 0.10[x(SnO 2 ) − (1 − x)rGO] with different weight percentages (x = 0, 0.15, 0.30, 0.45, 0.6, 0.75, 0.90 and 1) have been prepared by the hot press method. Chromium (Cr) has been deposited on the surface by using E-beam evaporation system, which is used as electrode of the device. Crystal structure, morphology, and electrical characteristics of the device have been explored for the technological application. A correlation between crystallinity, morphology, and electrical properties with these thick films has also been established. The device has been tested at different hydrogen (H 2 ) gas concentration as well as at different response times. A superior response of 0.90(PVDF) − 0.10[0.75(SnO 2 ) − 0.25 rGO] nanocomposite thick film has been observed. Hence, this composition is considered as optimized tertiary nanocomposite for the hydrogen gas sensor application. The sensor response of 49.2 and 71.4% with response time 34 sec and 52 sec for 100 PPM and 1000 PPM H 2 gas concentration respectively have been obtained. First time a new kind of low cost and flexible polymer based nanocomposite thick film gas sensor has been explored.

No abstract

No abstract

Recent years have witnessed the introduction of several high-quality review articles into the literature covering various scientific and technical aspects of bioanalysis. Now it is widely accepted that bioanalysis is an integral part of the pharmacokinetic/pharmacodynamic characterization of a novel chemical entity from the time of its discovery and during various stages of drug development, leading to its market authorization. In this compilation, the important bioanalytical parameters and its application to drug discovery and development approaches are discussed, which will help in the development of safe and more efficacious drugs with reduced development time and cost. It is intended to give some general thoughts in this area which will form basis of a general framework as to how one would approach bioanalysis from inception (i.e., discovery of a lead molecule) and progressing through various stages of drug development.

No abstract